INSM

Q: What is the price of Insmed (INSM) today?

The price of Insmed (INSM) today is R$ 716,36, with a variation of 75.73% compared to the last year. The price of Insmed (INSM) started the year trading around R$ 374,20 and today it is at R$ 716,36. Follow the real-time price chart, the historical price of Insmed (INSM), and stock data from Ibovespa and international markets.

Q: When does Insmed (INSM) pay dividends?

Insmed (INSM) did not distribute dividends in the last year.

Q: Insmed (INSM) is it worth it?

Currently, Insmed (INSM) is priced at R$ 716,36, with a P/E of -24,10%, representing a deviation of -11,23% from its historical average P/E. In the last year, the stock showed a variation of 75.73% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 75,73%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Insmed (INSM)?

Investing in shares of Insmed (INSM) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Insmed (INSM) yield today?

The yield of Insmed (INSM) was 27,15% in the last month, 75,73% in the last year and 359,24% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Insmed (INSM) today, the total investment would be based on the current price of R$ 716,36.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 125.886,19In 5 years: R$ 328.981,81In 10 years: 387.401,08It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Insmed Incorporated

Price

US$ 132,17

variation (12m)

75,73%

p/l

-24,10

p/vp

19,94

DIVIDEND YIELD

0,00%

quote INSM

BVMF

INSM

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of INSM

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

27,15%

3 months

99,17%

1 year

75,73%

2 years

511,33%

5 years

359,24%

10 years

440,79%

real profitability

profitability minus inflation.

1 month

27,15%

3 months

98,18%

1 year

66,97%

2 years

457,24%

5 years

235,57%

10 years

220,60%

Indicators INSM

check out the fundamentals of Insmed shares

P/L

-24,10

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

62,61

Sector: -3,77 Industry: -3,77

P/VP

19,94

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-41,71%

Sector: -63,50% Industry: -63,50%

ROE

-82,77%

Sector: -67,23% Industry: -67,23%

ROIC

-206,15%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

-100,00%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

75,72%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

-100,00%

Sector: -43,21% Industry: -43,21%

P/EBITDA

-26,57

Sector: -3,13 Industry: -3,13

P/EBIT

-26,22

Sector: -3,41 Industry: -3,41

P/ASSETS

10,05

Sector: 1,29 Industry: 1,29

VPA

6,61

Sector: 1,80 Industry: 1,80

LPA

-5,47

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,50

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

19,35%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

28,60%

Sector: - Industry: -

INSM indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of INSM with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history INSM dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Insmed

Insmed Incorporated

Average user rating I10

4.0 (1 people)

Estados Unidos

26 years

Foundation: 1999

2000

Year of debut on the stock exchange - 25 years

521

Employees

The Company Insmed Incorporated (Estados Unidos), is listed on Nasdaq with a market value of $ 24,93 Billions, having a net worth of $ 1,25 Billion.

With a total of 521 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 398,10 Milhões, which generated a loss in the amount of $ -1,03 Billion.

As for its main indicators, the Company has a P/E ratio of -24,10, a P/B ratio of 19,94 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker INSM.

Market value

US$ 24,93 Billions

Net worth

US$ 1,25 Billion

US$ 1.249.730.000,00

Assets

US$ 2,48 Billions

US$ 2.479.860.000,00

Total Number of Shares

189,00 Milhões

189.000.000

Average Daily Trading Volume

US$ 3,79 Milhões

US$ 3.794.429,60

Sector

Cuidados de saúde

Industry

Biotecnologia

INSM

INSM revenue and profits

INSM results

DRAG THE FRAME TO SEE MORE DATA

INSM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Insmed (INSM) today?

The price of Insmed (INSM) today is R$ 716,36, with a variation of 75.73% compared to the last year. The price of Insmed (INSM) started the year trading around R$ 374,20 and today it is at R$ 716,36. Follow the real-time price chart, the historical price of Insmed (INSM), and stock data from Ibovespa and international markets.

When does Insmed (INSM) pay dividends?

Insmed (INSM) did not distribute dividends in the last year.

Insmed (INSM) is it worth it?

Currently, Insmed (INSM) is priced at R$ 716,36, with a P/E of -24,10%, representing a deviation of -11,23% from its historical average P/E. In the last year, the stock showed a variation of 75.73% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 75,73%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Insmed (INSM)?

Investing in shares of Insmed (INSM) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Insmed (INSM) yield today?

The yield of Insmed (INSM) was 27,15% in the last month, 75,73% in the last year and 359,24% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Insmed (INSM) today, the total investment would be based on the current price of R$ 716,36.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 125.886,19
In 5 years: R$ 328.981,81
In 10 years: 387.401,08

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

INSM

Insmed Incorporated

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of INSM

check out the fundamentals of Insmed shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Insmed

Insmed Incorporated

Estados Unidos

26 years

2000

521

PROFIT X PRICE INSM

INSM results

INSM cash flow

evolution of assets - INSM

INSM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80